ARCHIVES

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

This article is from The Cancer Letter archive.

Vol. 32 No. 14 | April 14, 2006

Download PDF Visit The Full Archive

Related Articles

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

More Concept Approvals By DCPC Board

May 18, 1984

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

In Brief: ACS Awards Three More Grants For Prevention Research; AHF Establishes Chair In Nutrition

November 14, 1980

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989